Is high dose intravenous acetaminophen affect liver function in premature neonates with patent ductus arteriosus? (original) (raw)
Does high dose intravenous acetaminophen affect liver function for PDA closure in premature neonate?
Hamid Amoozgar
Italian Journal of Pediatrics
View PDFchevron_right
Comparison of Therapeutic Effect and Safety of Oral and Rectal Use of Acetaminophen on Patent Ductus Arteriosus in Preterm Infants: Clinical Randomized Trial
Roya lorestani
Global Pediatric Health
View PDFchevron_right
Comparison of the effect of oral acetaminophen and ibuprofen on patent ductus arteriosus closure in premature infants referred to hajar hospital in Shahrekord in 2016-2017
afsaneh malekpour
Journal of Clinical Neonatology, 2018
View PDFchevron_right
The Effect of Oral Acetaminophen on Open Arterial Duct Closure in Premature Infants Less Than 32 Weeks
abdollah dehvari
Romanian Journal of Cardiology
View PDFchevron_right
Acetaminophen vs. Ibuprofen in Early Treatment of Patent Ductus Arteriosus in Preterm Infants: A Non-Inferiority Randomized Clinical Trial
ScienceVolks Open Access
SVOA Paediatrics, 2022
View PDFchevron_right
A Comparison between the Safety and Efficacy of IV Paracetamol (Acetaminophen) and IV Ibuprofen in Treating Premature Neonates with Patent Ductus Arteriosus
Abolfazl ebadi
2019
View PDFchevron_right
Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus
Afif El-khuffash
The Journal of thoracic and cardiovascular surgery, 2018
View PDFchevron_right
Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates
Marwa Elgendy
European Journal of Pediatrics, 2016
View PDFchevron_right
Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
Fumihiko Namba
American Journal of Perinatology Reports
View PDFchevron_right
Efficacy and safety of paracetamol versus ibuprofen for treating patent ductus arteriosus in preterm infants: A meta-analysis
Kamaldeep Arora
Journal of Clinical Neonatology, 2014
View PDFchevron_right
Intravenous paracetamol and patent ductus arteriosus closure in preterm infants
Mulyadi Djer
Paediatrica Indonesiana, 2017
View PDFchevron_right
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Ana García-Robles
Frontiers in Pediatrics, 2020
View PDFchevron_right
Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus
Gabriella Errico
Fundamental and Clinical Pharmacology, 2005
View PDFchevron_right
Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial
Gianluca Lista
Trials, 2016
View PDFchevron_right
Therapeutic Effect and Safety of Early Treatment of Patent Ductus Arteriosus with Oral Ibuprofen in Preterm Infants
Alketa Hoxha
2015
View PDFchevron_right
Renal Effects of Ibuprofen during the Treatment of Patent Ductus Arteriosus in Low Birth Weight Premature Infants
Gentian Vyshka
Science Journal of Clinical Medicine, 2015
View PDFchevron_right
Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis
Sinno Simons
Archives of Disease in Childhood - Fetal and Neonatal Edition
View PDFchevron_right
Effect of oral Ibuprofen in ductus arteriosus closure in preterm infants
Parisa Mohagheghi
DOAJ (DOAJ: Directory of Open Access Journals), 2010
View PDFchevron_right
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis
Argie Veroniki
JAMA, 2018
View PDFchevron_right
Comparison of intravenous Paracetamol with oral Ibuprofen for medical closure of PDA (patent ductus arteriosus) in preterm newborns – can it be an effective, safe and preferable choice?
smit shrivastava
2021
View PDFchevron_right
iPAPP: study protocol for a multicentre randomised controlled trial comparing safety and efficacy of intravenous paracetamol and indomethacin for the treatment of patent ductus arteriosus in preterm infants
Fumihiko Namba
BMJ Open
View PDFchevron_right
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants A Systematic Review and Network Meta-analysis
Ivan D Florez
JAMA, 2018
View PDFchevron_right
EFFECTIVENESS AND SAFETY OF HIGH DOSE ORAL IBUPROFEN VERSUS STANDARD DOSE FOR TREATMENT OF PRETERM INFANTS WITH PATENT DUCTUS ARTERIOSUS Original Article YAOWARET MEKKHAYAI a , CHULEEGONE SORNSUVIT b , KANCHANA PREEDISRIPIPAT c , SORAWIT PONGPITTAYUT c
International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS)
International Journal of Pharmacy and Pharmaceutical Sciences, 2015
View PDFchevron_right
Oral versus intravenous paracetamol: which is better in closure of patent ductus arteriosus in very low birth weight infants?
Fahri Ovalı
The Journal of Maternal-Fetal & Neonatal Medicine, 2014
View PDFchevron_right
Treatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newborns
Gabriele Messina
Journal of Maternal-Fetal and Neonatal Medicine, 2013
View PDFchevron_right
High-Dose Ibuprofen for Patent Ductus Arteriosus in Extremely Preterm Infants: A Randomized Controlled Study
Riccardo Ciuti
Clinical Pharmacology & Therapeutics, 2011
View PDFchevron_right